Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024

May 9, 2024

https://www.globenewswire.com/news-release/2024/05/09/2879084/15114/en/Lumos-Pharma-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Clinical-Update-on-May-15-2024.html

AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first quarter 2024 financial results before market open on Wednesday, May 15, 2024. The company will host a conference call and webcast at 8:30 AM ET that day to discuss these financial results and provide an update on clinical and corporate activities. A question-and-answer session will follow the prepared remarks.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.